Ledger.Open graph →
SEC Form D · filed September 29, 2020

Viridian Therapeutics, Inc

Offering
$27.0M
Sold
$27.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Peter Harwin · Waltham, MADirectorTomas Kiselak · Waltham, MADirectorJonathan Violin · Waltham, MAExec · DirectorSteve Gallo · Louisville, KYDirectorBen Streepey · Louisville, KYDirectorHeather K. Goodman · San Francisco, CAExec · DirectorCamille Samuels · San Diego, CAExec · DirectorJack Nielsen · San Diego, CADirectorJeffrey Pentland · Toronto, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗